COVID-19 Vaccines and Coverage

In the face of the COVID-19 pandemic, pharmaceutical companies have moved to produce vaccines. The Food and Drug Administration (FDA) awarded an Emergency Use Authorization (EUA) to three companies for their vaccines: Pfizer on Dec. 11, 2020, Moderna on Dec. 18, 2020, and Janssen Pharmaceutical Companies of Johnson & Johnson on Feb. 27, 2021. On Aug. 23, 2021, they granted full approval of the Pfizer COVID-19 vaccine for ages 16 and older. The Pfizer vaccine, known as Comirnaty is also available under EUA for ages 5-15. See the FDA website for prescribing information.

Booster Shots and Additional Doses: The federal government requires us to cover the COVID-19 vaccine at no cost share through the end of the public health emergency (PHE). This includes COVID-19 booster shots and additional doses. Members may choose to receive the vaccine type they originally received or a different type as a booster shot. CDC recommendations allow for mix-and-match dosing for booster shots. The CDC provides guidance on the administration of the vaccine. At the end of the PHE, we will provide updates on our coverage.

Initially, the federal government will pay for the vaccine. Blue Cross and Blue Shield of Oklahoma (BCBSOK), or self-funded groups, will cover administration of the vaccine as noted below:

Fully insured:

• Vaccine and administration covered as a preventive service with no cost-share to members at in-network providers
• Vaccine and administration covered with no cost-share to members if delivered at out-of-network providers through the end of the public health emergency

Self-funded employer groups:

• Non-grandfathered self-funded employer groups - vaccine and administration covered as a preventive service with no cost-share to members at in-network providers
• Vaccine and administration covered at no cost-share to members at out-of-network providers through the end of the public health emergency
• Self-funded employer groups that don't cover preventive vaccines through their pharmacy benefit must cover the vaccine through their medical benefit
• Grandfathered plans are not required to cover preventive services, including the COVID-19 vaccine

Medicare Advantage

• Through Dec. 31, 2021: Submit claims for the vaccine and its administration to the CMS Medicare Administrative Contractor using product-specific codes for each vaccine approved. Payment for the vaccine and its administration is through the original fee-for-service Medicare program until the end of 2021.
• Starting Jan. 1, 2022: BCBSOK will cover the cost of COVID-19 vaccines and their administration for Medicare Advantage members. For Medicare Advantage members you vaccinate on or after Jan. 1, follow your normal submission process to BCBSOK or see the member’s ID card for billing instructions.
• Medicare Advantage members will continue to have no cost-sharing during their 2022 benefit year on vaccines and their administration, including approved booster doses.

Medicare Supplement

• Submit claims for the vaccine and its administration to CMS. Payment is through the original fee-for-service Medicare program.

Reimbursement:

• In-network providers will be reimbursed for the administration fee based on contracted rates.
• Out-of-network providers will be reimbursed based on established OON reimbursement policy that follows Medicare rates.

Balance billing: Providers are prohibited from billing patients for the vaccine or its administration, including balance billing, if the provider received the vaccine at no cost from the government.

Coding claims: CMS and the American Medical Association (AMA) have identified the codes to use in submitting claims. For more information, see CMS' guidance .

When billing a vaccine administration code with an office visit, if the vaccine is not the primary purpose of the office visit, bill the vaccine on a separate claim.

Dosage: Candidate vaccines may require one or two doses. The Pfizer and Moderna vaccines require two doses. The Janssen/Johnson & Johnson vaccine is one dose. Guidance on additional doses is evolving. Follow CDC guidelines .

More information:

• CDC COVID-19 Vaccination Program Interim Playbook  for Jurisdiction Operations
• Provider Relief Fund – for reimbursement for administering the COVID-19 vaccine to the uninsured
• CMS guidance  on Medicare billing for the COVid-19 vaccine administration

We continue to monitor information provided by the CDC and other government and health officials. We'll provide updates when we have them. For the latest information on COVID-19, we recommend visiting the CDC's COVID-19 website .

By clicking this link, you will go to a new website/app ("site"). This new site may be offered by a vendor or an independent third party. The site may also contain non-Medicare related information. In addition, some sites may require you to agree to their terms of use and privacy policy.